Gastroenteropancreatic neuroendocrine tumours IM Modlin, K Oberg, DC Chung, RT Jensen, WW De Herder, RV Thakker, ... The lancet oncology 9 (1), 61-72, 2008 | 2102 | 2008 |
ACG clinical guideline: treatment of Helicobacter pylori infection WD Chey, GI Leontiadis, CW Howden, SF Moss Official journal of the American College of Gastroenterology| ACG 112 (2 …, 2017 | 1925 | 2017 |
Induction of gastric epithelial apoptosis by Helicobacter pylori. SF Moss, J Calam, B Agarwal, S Wang, PR Holt Gut 38 (4), 498-501, 1996 | 620 | 1996 |
Chromogranin A—biological function and clinical utility in neuro endocrine tumor disease IM Modlin, BI Gustafsson, SF Moss, M Pavel, AV Tsolakis, M Kidd Annals of surgical oncology 17, 2427-2443, 2010 | 534 | 2010 |
Helicobacter pylori cagA + Strains and Dissociation of Gastric Epithelial Cell Proliferation From Apoptosis RM Peek Jr, SF Moss, S Wang, PR Holt, KT Tham, MJ Blaser, ... Journal of the National Cancer Institute 89 (12), 863-868, 1997 | 490 | 1997 |
Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set DS Klimstra, IR Modlin, NV Adsay, R Chetty, V Deshpande, M Gönen, ... The American journal of surgical pathology 34 (3), 300-313, 2010 | 464 | 2010 |
Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas M Krajewska, SF Moss, S Krajewski, KI Song, PR Holt, JC Reed Cancer Research 56 (10), 2422-2427, 1996 | 437 | 1996 |
Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses DA Israel, N Salama, CN Arnold, SF Moss, T Ando, HP Wirth, KT Tham, ... The Journal of clinical investigation 107 (5), 611-620, 2001 | 431 | 2001 |
Mechanisms of disease: inflammation and the origins of cancer SF Moss, MJ Blaser Nature clinical practice Oncology 2 (2), 90-97, 2005 | 422 | 2005 |
Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis N Arber, H Hibshoosh, SF Moss, T Sutter, Y Zhang, M Begg, S Wang, ... Gastroenterology 110 (3), 669-674, 1996 | 421 | 1996 |
Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease SF Moss, J Calam, S Legon, AE Bishop, JM Polak The Lancet 340 (8825), 930-932, 1992 | 396 | 1992 |
Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells B Agarwal, S Bhendwal, B Halmos, SF Moss, WG Ramey, PR Holt Clinical Cancer Research 5 (8), 2223-2229, 1999 | 357 | 1999 |
The clinical evidence linking Helicobacter pylori to gastric cancer SF Moss Cellular and molecular gastroenterology and hepatology 3 (2), 183-191, 2017 | 345 | 2017 |
Consensus on biomarkers for neuroendocrine tumour disease K Oberg, IM Modlin, W De Herder, M Pavel, D Klimstra, A Frilling, DC Metz, ... The Lancet Oncology 16 (9), e435-e446, 2015 | 337 | 2015 |
Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors IM Modlin, SF Moss, DC Chung, RT Jensen, E Snyderwine JNCI: Journal of the National Cancer Institute 100 (18), 1282-1289, 2008 | 320 | 2008 |
Helicobacter pylori virulence factors in gastric carcinogenesis S Wen, SF Moss Cancer letters 282 (1), 1-8, 2009 | 305 | 2009 |
Reconciliation of recent Helicobacter pylori treatment guidelines in a time of increasing resistance to antibiotics CA Fallone, SF Moss, P Malfertheiner Gastroenterology 157 (1), 44-53, 2019 | 290 | 2019 |
Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma SS Kim, VE Ruiz, JD Carroll, SF Moss Cancer letters 305 (2), 228-238, 2011 | 283 | 2011 |
Houston consensus conference on testing for Helicobacter pylori infection in the United States HB El-Serag, JY Kao, F Kanwal, M Gilger, F LoVecchio, SF Moss, ... Clinical Gastroenterology and Hepatology 16 (7), 992-1002. e6, 2018 | 272 | 2018 |
Diagnosis and management of non-erosive reflux disease–the Vevey NERD Consensus Group IM Modlin, RH Hunt, P Malfertheiner, P Moayyedi, EM Quigley, GNJ Tytgat, ... Digestion 80 (2), 74-88, 2009 | 272 | 2009 |